Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Primary Results of ROSE/TRIO-12, a Randomized Placebo-Controlled Phase III Trial Evaluating the Addition of Ramucirumab to First-Line Docetaxel Chemotherapy in Metastatic Breast CancerJohn R. Mackey Manuel Ramos-Vazquez Oleg Lipatov,; Nicole McCarthy; Dmitriy Krasnozhon; Vladimir Semiglazov; Alexey Manikhas; Karen A Gelmon; Gottfried E Konecny; Marc Webster; Roberto Hegg; Sunil Verma; Vera Gorbunova; Dany Abi Gerges; Francois Thireau; Helena Fung; Lorinda Simms; Marc Buyse; Ayman Ibrahim; Miguel MartinJournal of Clinical Oncology New York v. 33, n. 2, p. 141-148, 2015New York 2015Acesso online. A biblioteca também possui exemplares impressos. |
|
2 |
Material Type: Artigo
|
ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)Paluch-Shimon, S. ; Cardoso, F. ; Partridge, A.H. ; Abulkhair, O. ; Azim, H.A. ; Bianchi-Micheli, G. ; Cardoso, M.-J. ; Curigliano, G. ; Gelmon, K.A. ; Harbeck, N. ; Merschdorf, J. ; Poortmans, P. ; Pruneri, G. ; Senkus, E. ; Spanic, T. ; Stearns, V. ; Wengström, Y. ; Peccatori, F. ; Pagani, O.Annals of oncology, 2020-06, Vol.31 (6), p.674-696 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
3 |
Material Type: Artigo
|
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)Cardoso, F. ; Paluch-Shimon, S. ; Senkus, E. ; Curigliano, G. ; Aapro, M.S. ; André, F. ; Barrios, C.H. ; Bergh, J. ; Bhattacharyya, G.S. ; Biganzoli, L. ; Boyle, F. ; Cardoso, M.-J. ; Carey, L.A. ; Cortés, J. ; El Saghir, N.S. ; Elzayat, M. ; Eniu, A. ; Fallowfield, L. ; Francis, P.A. ; Gelmon, K. ; Gligorov, J. ; Haidinger, R. ; Harbeck, N. ; Hu, X. ; Kaufman, B. ; Kaur, R. ; Kiely, B.E. ; Kim, S.-B. ; Lin, N.U. ; Mertz, S.A. ; Neciosup, S. ; Offersen, B.V. ; Ohno, S. ; Pagani, O. ; Prat, A. ; Penault-Llorca, F. ; Rugo, H.S. ; Sledge, G.W. ; Thomssen, C. ; Vorobiof, D.A. ; Wiseman, T. ; Xu, B. ; Norton, L. ; Costa, A. ; Winer, E.P.Annals of oncology, 2020-12, Vol.31 (12), p.1623-1649 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
4 |
Material Type: Artigo
|
ESO–ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)Paluch-Shimon, S. ; Cardoso, F. ; Partridge, A.H. ; Abulkhair, O. ; Azim, H.A. ; Bianchi-Micheli, G. ; Cardoso, M.J. ; Curigliano, G. ; Gelmon, K.A. ; Gentilini, O. ; Harbeck, N. ; Kaufman, B. ; Kim, S.B. ; Liu, Q. ; Merschdorf, J. ; Poortmans, P. ; Pruneri, G. ; Senkus, E. ; Sirohi, B. ; Spanic, T. ; Sulosaari, V. ; Peccatori, F. ; Pagani, O.Annals of oncology, 2022-11, Vol.33 (11), p.1097-1118 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
5 |
Material Type: Artigo
|
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-upRugo, H. S. ; Finn, R. S. ; Diéras, V. ; Ettl, J. ; Lipatov, O. ; Joy, A. A. ; Harbeck, N. ; Castrellon, A. ; Iyer, S. ; Lu, D. R. ; Mori, A. ; Gauthier, E. R. ; Bartlett, C. Huang ; Gelmon, K. A. ; Slamon, D. J.Breast cancer research and treatment, 2019-04, Vol.174 (3), p.719-729 [Periódico revisado por pares]New York: Springer USTexto completo disponível |
|
6 |
Material Type: Artigo
|
Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trialRugo, H.S. ; Diéras, V. ; Gelmon, K.A. ; Finn, R.S. ; Slamon, D.J. ; Martin, M. ; Neven, P. ; Shparyk, Y. ; Mori, A. ; Lu, D.R. ; Bhattacharyya, H. ; Bartlett, C.H.u.a.n.g. ; Iyer, S. ; Johnston, S. ; Ettl, J. ; Harbeck, N.Annals of oncology, 2018-04, Vol.29 (4), p.888-894 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
7 |
Material Type: Artigo
|
4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)Cardoso, F ; Senkus, E ; Costa, A ; Papadopoulos, E ; Aapro, M ; André, F ; Harbeck, N ; Aguilar Lopez, B ; Barrios, C H ; Bergh, J ; Biganzoli, L ; Boers-Doets, C B ; Cardoso, M J ; Carey, L A ; Cortés, J ; Curigliano, G ; Diéras, V ; El Saghir, N S ; Eniu, A ; Fallowfield, L ; Francis, P A ; Gelmon, K ; Johnston, S R D ; Kaufman, B ; Koppikar, S ; Krop, I E ; Mayer, M ; Nakigudde, G ; Offersen, B V ; Ohno, S ; Pagani, O ; Paluch-Shimon, S ; Penault-Llorca, F ; Prat, A ; Rugo, H S ; Sledge, G W ; Spence, D ; Thomssen, C ; Vorobiof, D A ; Xu, B ; Norton, L ; Winer, E PAnnals of oncology, 2018-08, Vol.29 (8), p.1634-1657 [Periódico revisado por pares]England: Oxford University PressTexto completo disponível |
|
8 |
Material Type: Artigo
|
Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysisCurigliano, G. ; Mueller, V. ; Borges, V. ; Hamilton, E. ; Hurvitz, S. ; Loi, S. ; Murthy, R. ; Okines, A. ; Paplomata, E. ; Cameron, D. ; Carey, L.A. ; Gelmon, K. ; Hortobagyi, G.N. ; Krop, I. ; Loibl, S. ; Pegram, M. ; Slamon, D. ; Ramos, J. ; Feng, W. ; Winer, E.Annals of oncology, 2022-03, Vol.33 (3), p.321-329 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
9 |
Material Type: Artigo
|
Breast carcinoma—rare types: review of the literatureYerushalmi, R. ; Hayes, M. M. ; Gelmon, K. A.Annals of oncology, 2009-11, Vol.20 (11), p.1763-1770 [Periódico revisado por pares]Oxford: Oxford University PressTexto completo disponível |
|
10 |
Material Type: Artigo
|
Research needs in breast cancerCardoso, F. ; Harbeck, N. ; Barrios, C.H. ; Bergh, J. ; Cortés, J. ; El Saghir, N. ; Francis, P.A. ; Hudis, C.A. ; Ohno, S. ; Partridge, A.H. ; Sledge, G.W. ; Smith, I.E. ; Gelmon, K.A.Annals of oncology, 2017-02, Vol.28 (2), p.208-217 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |